Jaguar Health Reports 2022 Financial Results - Prescription Revenues ...
Jaguar Health Reports 2022 Financial Results - Prescription Revenues ...
Source: pr-inside.com
Ontarget Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ontarget Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ontarget Phase Today - Breaking & Trending Today
Jaguar Health, Inc.: Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials
Prescription product net revenue of approximately $3.1 million in Q3 2022 increased 8.2% over Q2 2022 and increased approximately 412% over prescription product net revenue in Q3 2021Core initiatives:OnTarget
Source: finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
Transaction proceeds will be allocated to support the company's ongoing OnTarget pivotal Phase 3 clinical trial of crofelemer for prophylaxis of diarrhea in adults receiving targeted cancer therapySAN
Source: finanznachrichten.de
Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors
Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Jaguar Health, Inc.: Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
Mytesi® net revenue of $2.6 million increased approximately 24% over the fourth quarter of 2021 and increased approximately 112% over Mytesi net revenue in the first quarter of 2021Core initiatives:OnTarget
Source: finanznachrichten.de